195 related articles for article (PubMed ID: 30957622)
1. Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway.
Ichikawa H; Shimada M; Narita M; Narita I; Kimura Y; Tanaka M; Osanai T; Okumura K; Tomita H
J Am Heart Assoc; 2019 Apr; 8(8):e012195. PubMed ID: 30957622
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice.
Narita M; Hanada K; Kawamura Y; Ichikawa H; Sakai S; Yokono Y; Senoo M; Narita N; Shimada M; Osanai T; Okumura K; Tomita H
Hypertens Res; 2021 Oct; 44(10):1261-1273. PubMed ID: 34285375
[TBL] [Abstract][Full Text] [Related]
3. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H
J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720
[TBL] [Abstract][Full Text] [Related]
4. Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin.
Ichikawa H; Narita I; Narita M; Tanno T; Yokono Y; Kimura Y; Tanaka M; Osanai T; Okumura K; Tomita H
Int Heart J; 2018 Nov; 59(6):1445-1453. PubMed ID: 30369568
[TBL] [Abstract][Full Text] [Related]
5. Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.
Oe Y; Hayashi S; Fushima T; Sato E; Kisu K; Sato H; Ito S; Takahashi N
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1525-33. PubMed ID: 27283743
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-κB Pathway.
Hashikata T; Yamaoka-Tojo M; Namba S; Kitasato L; Kameda R; Murakami M; Niwano H; Shimohama T; Tojo T; Ako J
Int Heart J; 2015; 56(5):544-50. PubMed ID: 26370374
[TBL] [Abstract][Full Text] [Related]
8. Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia.
Imano H; Kato R; Tanikawa S; Yoshimura F; Nomura A; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Hayashi T
J Pharmacol Sci; 2018 Jul; 137(3):274-282. PubMed ID: 30055890
[TBL] [Abstract][Full Text] [Related]
9. The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction.
Bode MF; Auriemma AC; Grover SP; Hisada Y; Rennie A; Bode WD; Vora R; Subramaniam S; Cooley B; Andrade-Gordon P; Antoniak S; Mackman N
Thromb Res; 2018 Jul; 167():128-134. PubMed ID: 29843086
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
Hayashi K; Sasamura H; Nakamura M; Sakamaki Y; Azegami T; Oguchi H; Tokuyama H; Wakino S; Hayashi K; Itoh H
Kidney Int; 2015 Oct; 88(4):745-53. PubMed ID: 26108068
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways.
Zhang Q; Zhang Z; Chen W; Zheng H; Si D; Zhang W
PeerJ; 2023; 11():e16097. PubMed ID: 37786576
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.
Moussa L; Apostolopoulos J; Davenport P; Tchongue J; Tipping PG
Am J Pathol; 2007 Sep; 171(3):800-8. PubMed ID: 17640968
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.
Zhang J; Patel MB; Griffiths R; Mao A; Song YS; Karlovich NS; Sparks MA; Jin H; Wu M; Lin EE; Crowley SD
Hypertension; 2014 Dec; 64(6):1275-81. PubMed ID: 25185128
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
[TBL] [Abstract][Full Text] [Related]
15. Roles of coagulation pathway and factor Xa in the progression of diabetic nephropathy in db/db mice.
Sumi A; Yamanaka-Hanada N; Bai F; Makino T; Mizukami H; Ono T
Biol Pharm Bull; 2011; 34(6):824-30. PubMed ID: 21628879
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
[TBL] [Abstract][Full Text] [Related]
17. Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation.
Matsuura T; Soeki T; Fukuda D; Uematsu E; Tobiume T; Hara T; Kusunose K; Ise T; Yamaguchi K; Yagi S; Yamada H; Wakatsuki T; Sata M
Circ J; 2021 Jul; 85(8):1383-1391. PubMed ID: 33746155
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.
Zhao Y; Wu J; Zhang M; Zhou M; Xu F; Zhu X; Zhou X; Lang Y; Yang F; Yun S; Shi S; Liu Z
J Mol Med (Berl); 2017 Aug; 95(8):887-898. PubMed ID: 28540409
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury.
Inoue K; Tian X; Velazquez H; Soda K; Wang Z; Pedigo CE; Wang Y; Cross E; Groener M; Shin JW; Li W; Hassan H; Yamamoto K; Mundel P; Ishibe S
J Am Soc Nephrol; 2019 Dec; 30(12):2307-2320. PubMed ID: 31511362
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.
Nasrallah R; Robertson SJ; Karsh J; Hébert RL
Clin Sci (Lond); 2013 Jun; 124(11):685-94. PubMed ID: 23305077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
